Multiple Myeloma: Plasma Cell Dyscrasias & CRAB Criteria
Multiple Myeloma (MM) is a monoclonal plasma cell neoplasm originating within the bone marrow. Neoplastic plasma cells synthesize and secrete massive quantities of a single, non-functional immunoglobulin or immunoglobulin fragment (most commonly IgG or IgA), which is detectable in the serum or urine. It is primarily a disease of older adults (median age around 65-70) and occurs more frequently in people of African descent.
1. Pathophysiology and Microenvironment
The clinical manifestations of Multiple Myeloma are driven by direct bone marrow infiltration, systemic toxicity from monoclonal proteins, and severe disruption of balanced bone remodeling structures:
- Osteoclast Activation: Neoplastic plasma cells secrete **RANKL** and **IL-6**, which stimulate osteoclasts to aggressively resorb bone while simultaneously inhibiting osteoblast activity. This causes painful, destructive bone erosion.
- The M-Protein Spike: Massive production of monoclonal immunoglobulins causes a narrow, sharp peak in the gamma globulin region on Serum Protein Electrophoresis (SPEP).
- Bence-Jones Proteins: Excess free light chains (kappa or lambda) pass easily through the glomerulus and filter into the urine, where they are detectable via Urine Protein Electrophoresis (UPEP) as Bence-Jones proteinuria.
Classic lateral skull radiograph revealing multiple well-circumscribed, non-sclerotic “punched-out” lytic bone lesions driven by neoplastic osteoclast activation.
2. Diagnostic Clinical Clues: The CRAB Criteria
The definitive clinical presentation of symptomatic multiple myeloma can be easily organized using the classic **CRAB** mnemonic:
| Clinical Manifestation | Underlying Pathophysiology | High-Yield Presentation / Findings |
|---|---|---|
| C – Calcium Elevation | Unchecked bone destruction releases massive quantities of calcium into the extracellular fluid, overwhelming renal clearance capabilities. | Hypercalcemia signs: Constipation, polyuria, nausea, confusion, and generalized lethargy (“groans, stones, psychiatric overtones”). |
| R – Renal Insufficiency | • **Myeloma Kidney:** Intraluminal free light chains precipitate inside distal convoluted tubules, binding with Tamm-Horsfall mucoprotein to form obstructive, toxic casts. • Secondary AL amyloidosis may deposit in glomeruli. |
Elevated BUN and creatinine. Note that standard urine dipsticks **miss free light chains** (they look specifically for albumin); definitive detection requires a 24-hour urine collection or sulfosalicylic acid (SSA) test. |
| A – Anemia | Neoplastic plasma cell overgrowth replaces normal hematopoietic tissue within the bone marrow niche, suppressing erythropoiesis. Renal damage also drops erythropoietin output. | Normocytic, normochromic anemia presenting as profound fatigue, weakness, and pallor. Elevated serum proteins eliminate normal RBC charges, causing them to stack like coins (**Rouleaux formation** on peripheral smear). |
| B – Bone Lesions | RANKL-driven focal bone resorption destroys trabecular architecture, leaving geographic structural defects. | Deep, boring bone pain (especially in the spine and ribs) that worsens with movement. Highly prone to **pathologic fractures** and vertebral column collapse. |
3. Morphological and Lab Identifiers
- Marrow Biopsy Cytology: Marrow is densely packed with clonal plasma cells (greater than or equal to 10% threshold required for diagnosis). These malignant cells display a characteristically eccentric nucleus, dark basophilic cytoplasm, and a prominent, pale, perinuclear Golgi zone (“clock-face” or “spoke-wheel” chromatin pattern). Russell bodies (cytoplasmic immunoglobulin inclusions) may be observed.
- Infection Vulnerability: Even though total immunoglobulins are highly elevated, they are monoclonal and completely useless. Normal polyclonal immunoglobulin production is profoundly suppressed, leaving patients highly susceptible to life-threatening infections from encapsulated organisms (such as Streptococcus pneumoniae and Haemophilus influenzae).
- Erythrocyte Sedimentation Rate (ESR): Characteristically massively elevated due to the presence of large quantities of circulating M-protein.
4. Spectrum of Plasma Cell Dyscrasias
It is essential to clinically differentiate Multiple Myeloma from other related plasma cell disorders along the spectrum of progression:
- Monoclonal Gammopathy of Undetermined Significance (MGUS): Characterized by an isolated serum M-protein spike of less than 3 g/dL and less than 10% clonal plasma cells in the bone marrow. Patients are completely **asymptomatic, without any CRAB findings**. MGUS carries a 1% per year risk of transformation into active Multiple Myeloma.
- Smoldering Multiple Myeloma: Serum M-protein is greater than or equal to 3 g/dL, or marrow plasma cells are between 10% and 60%. However, like MGUS, there are **no end-organ damage symptoms or CRAB criteria present**.
- Waldenström Macroglobulinemia: A distinct lymphoplasmacytic lymphoma characterized by an M-spike composed specifically of **monoclonal IgM**. Because IgM is a massive pentameric protein, its accumulation causes extreme **hyperviscosity syndrome** (visual disturbances, neurological symptoms, retinal hemorrhages, and a high risk of strokes) instead of the bone-lytic lesions seen with IgG/IgA in multiple myeloma.